
M K Proteins (MKPL) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
1.1B
Gross Profit
88.9M
7.73%
Operating Income
54.1M
4.70%
Net Income
35.1M
3.06%
EPS (Diluted)
₹0.09
Balance Sheet Metrics
Total Assets
1.3B
Total Liabilities
611.0M
Shareholders Equity
694.7M
Debt to Equity
0.88
Cash Flow Metrics
Operating Cash Flow
-14.9M
Free Cash Flow
-121.3M
Revenue & Profitability Trend
M K Proteins Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 2.7B | 2.5B | 3.1B | 2.6B | 3.1B |
Cost of Goods Sold | 2.5B | 2.2B | 2.9B | 2.4B | 2.9B |
Gross Profit | 167.3M | 216.5M | 204.9M | 186.8M | 186.2M |
Gross Margin % | 6.2% | 8.8% | 6.5% | 7.3% | 6.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 4.0M | 4.1M | 4.4M | 4.8M | 3.8M |
Other Operating Expenses | 10.0M | 13.4M | 6.6M | 5.6M | 5.7M |
Total Operating Expenses | 14.0M | 17.5M | 11.0M | 10.4M | 9.4M |
Operating Income | 121.8M | 165.2M | 168.1M | 147.9M | 151.0M |
Operating Margin % | 4.6% | 6.7% | 5.3% | 5.8% | 4.9% |
Non-Operating Items | |||||
Interest Income | 0 | 102.4K | 115.9K | 298.0K | 69.2K |
Interest Expense | 11.0M | 11.2M | 18.4M | 8.3M | 7.5M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 114.5M | 154.7M | 149.9M | 140.4M | 143.2M |
Income Tax | 30.5M | 42.6M | 40.6M | 38.6M | 39.3M |
Effective Tax Rate % | 26.7% | 27.5% | 27.1% | 27.5% | 27.5% |
Net Income | 84.0M | 112.1M | 109.3M | 101.8M | 103.9M |
Net Margin % | 3.1% | 4.6% | 3.5% | 4.0% | 3.3% |
Key Metrics | |||||
EBITDA | 124.8M | 170.9M | 176.4M | 157.4M | 159.4M |
EPS (Basic) | ₹0.22 | ₹0.30 | ₹0.29 | ₹0.27 | ₹0.83 |
EPS (Diluted) | ₹0.22 | ₹0.30 | ₹0.29 | ₹0.27 | ₹0.83 |
Basic Shares Outstanding | 381701013 | 375372000 | 375372000 | 375372000 | 125124000 |
Diluted Shares Outstanding | 381701013 | 375372000 | 375372000 | 375372000 | 125124000 |
Income Statement Trend
M K Proteins Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 337.9K | 923.2K | 624.8K | 66.6K | 12.6K |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 14.0M | 35.7M | 160.6M | 283.8M | 206.5M |
Inventory | 1.1B | 792.7M | 712.0M | 497.7M | 377.0M |
Other Current Assets | 57.5M | 29.1M | - | 0 | 17.4K |
Total Current Assets | 1.2B | 858.4M | 985.8M | 800.2M | 642.0M |
Non-Current Assets | |||||
Property, Plant & Equipment | 800.5K | 800.5K | 800.5K | 10.8M | 24.5M |
Goodwill | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 10.3M | 9.1M | - | - | - |
Total Non-Current Assets | 120.5M | 104.1M | 46.4M | 50.7M | 31.5M |
Total Assets | 1.3B | 962.5M | 1.0B | 850.9M | 673.5M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 193.1M | 114.9M | 48.0M | 50.3M | 80.4M |
Short-term Debt | 369.4M | 191.1M | 420.0M | 341.3M | 206.8M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 13.1M | 8.1M | - | 0 | - |
Total Current Liabilities | 590.0M | 339.6M | 496.3M | 423.8M | 335.1M |
Non-Current Liabilities | |||||
Long-term Debt | 17.8M | 9.7M | 35.3M | 36.6M | 44.5M |
Deferred Tax Liabilities | - | - | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | - | - | 0 | - |
Total Non-Current Liabilities | 21.0M | 12.1M | 37.3M | 38.1M | 45.0M |
Total Liabilities | 611.0M | 351.7M | 533.6M | 461.9M | 380.1M |
Equity | |||||
Common Stock | 375.4M | 375.4M | 125.1M | 41.7M | 41.7M |
Retained Earnings | 319.6M | 235.6M | 290.1M | 264.0M | 168.1M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 694.7M | 610.8M | 498.6M | 389.0M | 293.4M |
Key Metrics | |||||
Total Debt | 387.2M | 200.8M | 455.3M | 377.9M | 251.3M |
Working Capital | 595.1M | 518.8M | 489.5M | 376.5M | 306.9M |
Balance Sheet Composition
M K Proteins Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 114.5M | 154.7M | 149.9M | 140.4M | 143.2M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -322.7M | 125.2M | -180.0M | -154.1M | -108.0M |
Operating Cash Flow | -197.1M | 290.5M | -11.9M | -5.6M | 42.7M |
Investing Activities | |||||
Capital Expenditures | -20.4M | -59.0M | -72.1K | -15.7M | 0 |
Acquisitions | - | - | - | - | - |
Investment Purchases | -193.5M | -29.7M | -45.5M | -202.0M | -36.5M |
Investment Sales | 199.1M | 29.9M | 45.6M | 202.5M | 36.9M |
Investing Cash Flow | -14.8M | -58.9M | 18.0K | -15.6M | 410.6K |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 13.3M | 0 | 0 | 28.5M | 50.1M |
Debt Repayment | -1.6M | -26.1M | -1.0M | -51.0M | -41.1M |
Financing Cash Flow | 186.6M | -254.3M | 77.4M | 116.6M | -54.4M |
Free Cash Flow | -183.5M | 265.1M | -58.8M | -116.9M | 52.8M |
Net Change in Cash | -25.3M | -22.7M | 65.6M | 95.4M | -11.3M |
Cash Flow Trend
M K Proteins Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
28.79
Price to Book
3.97
Price to Sales
0.81
PEG Ratio
1.01
Profitability Ratios
Profit Margin
2.90%
Operating Margin
4.70%
Return on Equity
12.09%
Return on Assets
6.43%
Financial Health
Current Ratio
2.01
Debt to Equity
55.75
Beta
-0.44
Per Share Data
EPS (TTM)
₹0.24
Book Value per Share
₹1.74
Revenue per Share
₹8.33
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
mkpl | 2.8B | 28.79 | 3.97 | 12.09% | 2.90% | 55.75 |
Nestle India | 2.3T | 72.48 | 56.26 | 79.99% | 15.21% | 29.11 |
Britannia Industries | 1.4T | 65.29 | 32.96 | 49.73% | 12.02% | 28.45 |
Gujarat Ambuja | 49.1B | 20.54 | 1.62 | 8.30% | 4.94% | 7.62 |
Heritage Foods | 46.4B | 26.52 | 4.65 | 19.37% | 4.02% | 17.95 |
Gopal Snacks | 44.1B | 237.52 | 10.66 | 4.69% | -0.19% | 16.43 |
Financial data is updated regularly. All figures are in the company's reporting currency.